Source: Annual Congress 2007 - Chronic lung disease of prematurity: pathogenesis and outcomes
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. L. Davies, N. C. Maxwell, O. B. Spiller, E. Remmell-O¿Donnell, S. Kotecha (Cardiff, United Kingdom; Boston, MA, United States Of America). The role of anti-proteases in the development of chronic lung disease of prematurity (CLD). Eur Respir J 2007; 30: Suppl. 51, 4410

Member's Comments

No comment yet.

Related content which might interest you: The role of proteases in the development of chronic lung disease of prematurity (CLD) Source: Eur Respir J 2007; 30: Suppl. 51, 393s Year: 2007 The role of infection in the development of chronic lung disease of prematurity Source: Annual Congress 2007 - Chronic lung disease of prematurity: pathogenesis and outcomes Year: 2007 The role of ASC signalling in preterm infants at risk of chronic lung disease of prematurity Source: International Congress 2018 – Prematurity and lung disease Year: 2018 The role of surfactant on chronic infant lung disease Source: Annual Congress 2003 - Chronic infant lung disease Year: 2003 Impact of prematurity on rabbit lung development: a key factor for mimicking chronic neonatal lung disease Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases Year: 2021 Angiogenesis in lung development, injury and repair: implications for chronic lung disease of prematurity Source: Annual Congress 2008 - Physiological year in review Year: 2008 Prognosis: what is the contribution of inflammation to the decline in lung function in airway disease? Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007 Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD Year: 2007 The role smoking in development of dust-indusde chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 608s Year: 2004 Senotherapies for chronic lung disease Source: ERS Lung Science Conference 2020 Year: 2020 Predictive factors for the incidence of lung cancer (LC) complicated in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2019 – Advances in clinical management of COPD Year: 2019 Delayed neutrophil apoptosis may predispose to lung injury in chronic lung disease of prematurity Source: Eur Respir J 2007; 30: Suppl. 51, 393s Year: 2007 Rate of progression of lung function impairment in α1-antitrypsin deficiency Source: Eur Respir J 2009; 33: 1338-1344 Year: 2009 Neonatal chronic lung disease and its long-term consequences Source: ISSN=1025-448x, ISBN=1-904097-22-7, page=99 Year: 2002 Surfactant protein B polymorphisms, pulmonary function and COPD in 10,231 individuals Source: Eur Respir J 2011; 37: 791-799 Year: 2011 Frequency and features of formation of chronic kidney disease (CKD) in patients with chronic obstructive pulmonary disease. Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Role of pulmonary infection in the development of chronic lung disease of prematurity Source: Eur Respir J 2011; 37: 1424-1430 Year: 2011 Walking strategy in severe chronic lung disease (CLD) patients Source: Eur Respir J 2005; 26: Suppl. 49, 309s Year: 2005